PAX1 and cervical cancer: The tumor suppressor paired box gene 1 (PAX1) was reported to present abnormal methylation in cervical cancer, and its methylation increased with disease grade, indicating the potential of PAX1 methylation as a biomarker for cervical cancer screening [11].